Clinical Trial Site

Goyang-si, Gyeonggi-do 411-706

1 studies enrolling now · 2 studies all time

What they study most

Atypical Hemolytic-Uremic Syndrome, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Locally Advanced Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now